To growing numbers of physicians nationwide, long lasting Radiesse® (Bioform Medical, Inc., San Mateo, Calif.) exemplifies the next generation dermal filler paving the way to the future of facial aesthetics.With its longevity, advanced mechanism of action, volumizing structure and contouring capabilities, Radiesse is ideally positioned to fill the gap between yesterday’s shortterm fillers and the potential risks of permanent fillers.

According to Thomas L. Tzikas, M.D., the augmentation benefits of Radiesse have been clinically proven to last an average of one year.He credits Radiesse’s sustained cosmetic correction to its advanced calciumbased microsphere technology, which creates a scaffold or matrix around which the body generates new collagen. Further, because Radiesse is a robust, full-bodied material, it provides physicians with a superior level of malleability and finesse for facial contouring applications. “Bioform’s proprietary microsphere technology is responsible for tissue anchoring as well as preserving the augmentation to the skin, resulting in both immediate and long-term beneficial effects with a single treatment of Radiesse,” explains Dr. Tzikas. “Additionally, the product’s dense composition translates to added versatility and value, with one syringe of Radiesse giving a better fill and more correction than similarly priced fillers.”

Radiesse has been successfully used off-label in facial aesthetics for over four years to improve the lower third of the face, particularly the nasolabial folds, marionette lines and prejowl sulcus. This product has also been used as a non-surgical, non-implant solution for augmenting cheeks, the sub-malar and zygomatic arch areas.

All patients are different, results depicted in the photographs are not necessarily representative of all results, and that individual results may vary.